129 related articles for article (PubMed ID: 25635421)
1. Nerve growth factor for the treatment of spinocerebellar ataxia type 3: an open-label study.
Tan S; Wang RH; Niu HX; Shi CH; Mao CY; Zhang R; Song B; Sun SL; Liu XJ; Hou HM; Liu YT; Gao Y; Fang H; Kong XD; Xu YM
Chin Med J (Engl); 2015 Feb; 128(3):291-4. PubMed ID: 25635421
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3.
Zesiewicz TA; Greenstein PE; Sullivan KL; Wecker L; Miller A; Jahan I; Chen R; Perlman SL
Neurology; 2012 Feb; 78(8):545-50. PubMed ID: 22323747
[TBL] [Abstract][Full Text] [Related]
3. Abnormal eye movements in spinocerebellar ataxia type 3.
Lin J; Zhang L; Cao B; Wei Q; Ou R; Hou Y; Xu X; Liu K; Gu X; Shang H
BMC Neurol; 2021 Jan; 21(1):28. PubMed ID: 33468086
[TBL] [Abstract][Full Text] [Related]
4. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
[TBL] [Abstract][Full Text] [Related]
5. Related factors of ICARS and SARA scores on spinocerebellar ataxia type 3/Machado-Joseph disease.
Zhou J; Lei L; Liao X; Wang J; Jiang H; Tang B; Shen L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):498-503. PubMed ID: 21743140
[TBL] [Abstract][Full Text] [Related]
6. Planning future clinical trials in Machado Joseph disease: Lessons from a phase 2 trial.
Saute JA; Rieder CR; Castilhos RM; Monte TL; Schumacher-Schuh AF; Donis KC; D'Ávila R; Souza GN; Russo AD; Furtado GV; Gheno TC; Souza DO; Saraiva-Pereira ML; Portela LV; Camey S; Torman VB; Jardim LB
J Neurol Sci; 2015 Nov; 358(1-2):72-6. PubMed ID: 26297649
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of NSE and S100B in spinocerebellar ataxia type 3/Machado-Joseph disease.
Zhou J; Lei L; Shi Y; Wang J; Jiang H; Shen L; Tang B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):504-10. PubMed ID: 21743141
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of valproic acid treatment in SCA3/MJD patients.
Lei LF; Yang GP; Wang JL; Chuang DM; Song WH; Tang BS; Jiang H
Parkinsonism Relat Disord; 2016 May; 26():55-61. PubMed ID: 26997655
[TBL] [Abstract][Full Text] [Related]
9. The correlation between magnetic resonance imaging features of the brainstem and cerebellum and clinical features of spinocerebellar ataxia 3/Machado-Joseph disease.
Liang X; Jiang H; Chen C; Zhou G; Wang J; Zhang S; Lei L; Wang X; Tang B
Neurol India; 2009; 57(5):578-83. PubMed ID: 19934555
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance spectroscopy of the cerebellum in patients with spinocerebellar ataxia type 3/Machado-Joseph disease.
Lei L; Liao Y; Liao W; Zhou J; Yuan Y; Wang J; Jiang H; Shen L; Tang B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):511-9. PubMed ID: 21743142
[TBL] [Abstract][Full Text] [Related]
11. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
[TBL] [Abstract][Full Text] [Related]
12. Differential Temporal Dynamics of Axial and Appendicular Ataxia in SCA3.
Maas RPPWM; Teerenstra S; Lima M; Pires P; Pereira de Almeida L; van Gaalen J; Timmann D; Infante J; Onyike C; Bushara K; Jacobi H; Reetz K; Santana MM; Afonso Ribeiro J; Hübener-Schmid J; de Vries JJ; Synofzik M; Schöls L; Garcia-Moreno H; Giunti P; Faber J; Klockgether T; van de Warrenburg BPC
Mov Disord; 2022 Sep; 37(9):1850-1860. PubMed ID: 35808813
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional Connections between Depression and Ataxia Severity in Spinocerebellar Ataxia Type 3 Patients.
Lin MT; Yang JS; Chen PP; Qian MZ; Lin HX; Chen XP; Shang XJ; Wang DN; Chen YC; Jiang B; Chen YJ; Chen WJ; Wang N; Gan SR
Eur Neurol; 2018; 79(5-6):266-271. PubMed ID: 29763923
[TBL] [Abstract][Full Text] [Related]
14. Patterns of motor signs in spinocerebellar ataxia type 3 at the start of follow-up in a reference unit.
Pulido-Valdeolivas I; Gómez-Andrés D; Sanz-Gallego I; Rausell E; Arpa J
Cerebellum Ataxias; 2016; 3():4. PubMed ID: 26909158
[TBL] [Abstract][Full Text] [Related]
15. A randomized, phase 2 clinical trial of lithium carbonate in Machado-Joseph disease.
Saute JA; de Castilhos RM; Monte TL; Schumacher-Schuh AF; Donis KC; D'Ávila R; Souza GN; Russo AD; Furtado GV; Gheno TC; de Souza DO; Portela LV; Saraiva-Pereira ML; Camey SA; Torman VB; de Mello Rieder CR; Jardim LB
Mov Disord; 2014 Apr; 29(4):568-73. PubMed ID: 24399647
[TBL] [Abstract][Full Text] [Related]
16. Association Between Body Mass Index and Disease Severity in Chinese Spinocerebellar Ataxia Type 3 Patients.
Yang JS; Chen PP; Lin MT; Qian MZ; Lin HX; Chen XP; Shang XJ; Wang DN; Chen YC; Jiang B; Chen YJ; Wang N; Chen WJ; Gan SR
Cerebellum; 2018 Aug; 17(4):494-498. PubMed ID: 29476441
[TBL] [Abstract][Full Text] [Related]
17. Schwann cell involvement in the peripheral neuropathy of spinocerebellar ataxia type 3.
Suga N; Katsuno M; Koike H; Banno H; Suzuki K; Hashizume A; Mano T; Iijima M; Kawagashira Y; Hirayama M; Nakamura T; Watanabe H; Tanaka F; Sobue G
Neuropathol Appl Neurobiol; 2014 Aug; 40(5):628-39. PubMed ID: 23617879
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features and gene mutation analysis in Machado-Joseph disease of spinocerebellar ataxia type 3 in littoral of Zhejiang].
Jin YY; Zeng AP; Cai HB; Wu F; Feng Z; Hong Q; Zhang L; Jiang ZK
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):132-4. PubMed ID: 20104758
[TBL] [Abstract][Full Text] [Related]
19. A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3.
Guimarães RP; D'Abreu A; Yasuda CL; França MC; Silva BH; Cappabianco FA; Bergo FP; Lopes-Cendes IT; Cendes F
Mov Disord; 2013 Jul; 28(8):1125-32. PubMed ID: 23553599
[TBL] [Abstract][Full Text] [Related]
20. Absence of spinocerebellar ataxia type 3/Machado-Joseph disease within ataxic patients in the Czech population.
Bauer PO; Zumrova A; Matoska V; Marikova T; Krilova S; Boday A; Singh B; Goetz P
Eur J Neurol; 2005 Nov; 12(11):851-7. PubMed ID: 16241973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
